The present application describes modulators of MCP-1 of formula (I): ##STR1## or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
The present application describes modulators of MCP-1 of formula (I): ##STR1##
or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
Web www.patentalert.com
< Automatic surgical sponge counter and blood loss determination system
< Thermotherapy via targeted delivery of nanoscale magnetic particles
> Use of (R)-peniciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
> Hybrid oligonucleotide phosphorothioates
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT
